High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant NPM1 and FLT3 Mutations

por Brodská, Barbora, Otevřelová, Petra, Šálek, Cyril, Fuchs, Ota, Gašová, Zdenka, Kuželová, Kateřina
Publicado 2019

Proteome changes of plasma-derived extracellular vesicles in patients with myelodysplastic syndrome

por Pecankova, Klara, Pecherkova, Pavla, Gasova, Zdenka, Sovova, Zofie, Riedel, Tomas, Jäger, Eliézer, Cermak, Jaroslav, Majek, Pavel
Publicado 2022

NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia

por Kuželová, Kateřina, Brodská, Barbora, Marková, Jana, Petráčková, Martina, Schetelig, Johannes, Ransdorfová, Šárka, Gašová, Zdenka, Šálek, Cyril
Publicado 2022

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer

por Podrazil, Michal, Horvath, Rudolf, Becht, Etienne, Rozkova, Daniela, Bilkova, Pavla, Sochorova, Klara, Hromadkova, Hana, Kayserova, Jana, Vavrova, Katerina, Lastovicka, Jan, Vrabcova, Petra, Kubackova, Katerina, Gasova, Zdenka, Jarolim, Ladislav, Babjuk, Marek, Spisek, Radek, Bartunkova, Jirina, Fucikova, Jitka
Publicado 2015